 |
> 2000 Publications
21.
Increasing the number of core samples taken at prostate
needle biopsy enhances the detection of clinically significant
prostate cancer.
Taylor JA, Gancarczyk KJ, Fant GV, McLeod DG.
Urology, 60(5):841-5, 2002. |
22.
Effect of race on biochemical disease-free outcome
in patients with prostate cancer treated with definitive radiation
therapy in an equal access health care system: radiation oncology
report of the Department of Defense Center for Prostate Disease
Research.
Johnstone PA, Kane CJ, Sun L, Wu H, Moul JW, McLeod DG, Martin
DD, Kusuda L, Lance R, Douglas R, Donahue T, Beat MG, Foley
J, Baldwin D, Soderdahl D, Do J, Amling CL.
Radiology, 225:420-6, 2002. |
23.
Radical prostatectomy versus radiation therapy for clinically
localized prostate carcinoma: the butcher and the baker selling
their wares.
Moul JW:
Cancer, 95:211-4, 2002. |
24.
Initiation of salvage therapy for prostate cancer.
Johnstone PA, Booth R, Riffenburgh RH, Amling CL, Kane CJ, Moul
JW:
Prostate Cancer Prostatic Dis, 5:136-43, 2002. |
25.
Adenocarcinoma of the prostate: an expensive way to
die.
Piper NY, Kusada L, Lance R, Foley J, Moul J, Seay T:
Prostate Cancer Prostatic Dis, 5:164-6, 2002. |
26.
Emerging role of adjuvant hormonal therapy.
McLeod DG.
Urology, 60(3 Suppl 1):13-20, 2002. |
27.
Overview consensus statement. Newer Approaches to androgen
deprivation therapy in prostate cancer. The 2nd International
Conference on Newer Approaches to Androgen Deprivation Therapy
(ADT) in Prostate Cancer.
Carroll PR, Kantoff PW, Balk SP, Brown MA D’amico AV,
George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee
WR, Lubeck DP, McLeod DG, Oh WK, Pollack A, Sartor O, Smith
MR, Hart C.
Urology, 60(3 Suppl 1):1-6, 2002. |
28.
Bicalutamide as immediate therapy either alone or as
adjuvant to standard care of patients with localized or locally
advanced prostate cancer: first analysis of the early prostate
cancer program.
See WA, Wirth MP, McLeod DG, et al.,
J Urol. 168:429-35, 2002. |
29.
Epidemiology of radical prostatectomy for localized
prostate cancer in the era of prostate specific antigen: an
overview of the Department of Defense Center for Prostate Disease
Research national database.
Moul JW, Wu H, Sun L, McLeod DG, Amling C, Lance R, Kusuda L,
Donahue T, Foley J, Chung A, Sexton W, Soderdahl D and Rich
NM.
Surgery, 132:213-9, 2002. |
30.
Diagnostic accuracy of prostate needle biopsy.
Donahue T, Moul J:
Curr Urol Rep, 3:215-21, 2002. |
31.
Molecular Dissection of the Prostate Cancer Genome.
Srikantan, V, and Srivastava S: R. Hoffman and A Heidenreich,
eds. In Prostate Cancer, Diagnosis and Surgical Treatment,
Springer-Verlag, 25-40. 2002. |
 Back
to Top |  Previous
Page |
|
